Cite
APA Citation
Garon, E. B., Wong, D. J., Schneider, J. G., Aljumaily, R., Korn, W. M., Patel, M. R., Autio, K. A., Papadopoulos, K. P., Naing, A., Gabrail, N., Munster, P. N., Goldman, J., Hung, A., Oft, M., Leveque, J., & Spigel, D. R. (n.d.). 1144PResponses and durability of clinical benefit in non-small cell lung cancer treated with pegilodecakin in combination with anti-PD-1 inhibitors. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095485048.0x00003c